Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 182

1.

Pharmacokinetic/pharmacodynamic profile of voriconazole.

Theuretzbacher U, Ihle F, Derendorf H.

Clin Pharmacokinet. 2006;45(7):649-63. Review.

PMID:
16802848
[PubMed - indexed for MEDLINE]
2.

Pharmacokinetic/pharmacodynamic profile of posaconazole.

Li Y, Theuretzbacher U, Clancy CJ, Nguyen MH, Derendorf H.

Clin Pharmacokinet. 2010 Jun;49(6):379-96. doi: 10.2165/11319340-000000000-00000. Review.

PMID:
20481649
[PubMed - indexed for MEDLINE]
3.

Voriconazole: therapeutic review of a new azole antifungal.

Herbrecht R.

Expert Rev Anti Infect Ther. 2004 Aug;2(4):485-97. Review.

PMID:
15482215
[PubMed - indexed for MEDLINE]
4.

The pharmacokinetics and safety of intravenous voriconazole - a novel wide-spectrum antifungal agent.

Purkins L, Wood N, Greenhalgh K, Eve MD, Oliver SD, Nichols D.

Br J Clin Pharmacol. 2003 Dec;56 Suppl 1:2-9.

PMID:
14616407
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.

Berge M, Guillemain R, Boussaud V, Pham MH, Chevalier P, Batisse A, Amrein C, Dannaoui E, Loriot MA, Lillo-Le Louet A, Billaud EM.

Transpl Infect Dis. 2009 Jun;11(3):211-9. doi: 10.1111/j.1399-3062.2009.00384.x. Epub 2009 Mar 17.

PMID:
19302272
[PubMed - indexed for MEDLINE]
6.

Voriconazole : a review of its use in the management of invasive fungal infections.

Scott LJ, Simpson D.

Drugs. 2007;67(2):269-98. Review.

PMID:
17284090
[PubMed - indexed for MEDLINE]
7.

Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype.

Scholz I, Oberwittler H, Riedel KD, Burhenne J, Weiss J, Haefeli WE, Mikus G.

Br J Clin Pharmacol. 2009 Dec;68(6):906-15. doi: 10.1111/j.1365-2125.2009.03534.x.

PMID:
20002085
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Voriconazole.

Jeu L, Piacenti FJ, Lyakhovetskiy AG, Fung HB.

Clin Ther. 2003 May;25(5):1321-81. Review.

PMID:
12867215
[PubMed - indexed for MEDLINE]
9.

Effect of omeprazole on the steady-state pharmacokinetics of voriconazole.

Wood N, Tan K, Purkins L, Layton G, Hamlin J, Kleinermans D, Nichols D.

Br J Clin Pharmacol. 2003 Dec;56 Suppl 1:56-61.

PMID:
14616415
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety.

Purkins L, Wood N, Greenhalgh K, Allen MJ, Oliver SD.

Br J Clin Pharmacol. 2003 Dec;56 Suppl 1:10-6.

PMID:
14616408
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

[Level of evidence for therapeutic drug monitoring of voriconazole].

Hulin A, Dailly E, Le Guellec C; Groupe Suivi Therapeutique Pharmacologique de la Societe Francaise de Pharmacologie et de Therapeutique.

Therapie. 2011 Mar-Apr;66(2):109-14. Epub 2011 Jun 6. Review. French.

PMID:
21635857
[PubMed - indexed for MEDLINE]
12.

Pharmacokinetics of voriconazole after oral administration of single and multiple doses in Hispaniolan Amazon parrots (Amazona ventralis).

Sanchez-Migallon Guzman D, Flammer K, Papich MG, Grooters AM, Shaw S, Applegate J, Tully TN.

Am J Vet Res. 2010 Apr;71(4):460-7. doi: 10.2460/ajvr.71.4.460.

PMID:
20367055
[PubMed - indexed for MEDLINE]
13.

Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens.

Purkins L, Wood N, Ghahramani P, Greenhalgh K, Allen MJ, Kleinermans D.

Antimicrob Agents Chemother. 2002 Aug;46(8):2546-53.

PMID:
12121931
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Pharmacology and clinical use of voriconazole.

Thompson GR 3rd, Lewis JS 2nd.

Expert Opin Drug Metab Toxicol. 2010 Jan;6(1):83-94. doi: 10.1517/17425250903463878. Review.

PMID:
19947892
[PubMed - indexed for MEDLINE]
15.

Review of the safety and efficacy of voriconazole.

Hoffman HL, Rathbun RC.

Expert Opin Investig Drugs. 2002 Mar;11(3):409-29. Review.

PMID:
11866669
[PubMed - indexed for MEDLINE]
16.

Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections.

Pascual A, Csajka C, Buclin T, Bolay S, Bille J, Calandra T, Marchetti O.

Clin Infect Dis. 2012 Aug;55(3):381-90. doi: 10.1093/cid/cis437. Epub 2012 May 18.

PMID:
22610925
[PubMed - indexed for MEDLINE]
Free Article
17.

No clinically significant effect of erythromycin or azithromycin on the pharmacokinetics of voriconazole in healthy male volunteers.

Purkins L, Wood N, Ghahramani P, Kleinermans D, Layton G, Nichols D.

Br J Clin Pharmacol. 2003 Dec;56 Suppl 1:30-6.

PMID:
14616411
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Voriconazole: a new triazole antifungal.

Sabo JA, Abdel-Rahman SM.

Ann Pharmacother. 2000 Sep;34(9):1032-43.

PMID:
10981251
[PubMed - indexed for MEDLINE]
19.

No clinically significant pharmacokinetic interactions between voriconazole and indinavir in healthy volunteers.

Purkins L, Wood N, Kleinermans D, Love ER.

Br J Clin Pharmacol. 2003 Dec;56 Suppl 1:62-8.

PMID:
14616416
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Pharmacokinetics and tolerability of voriconazole and a combination oral contraceptive co-administered in healthy female subjects.

Andrews E, Damle BD, Fang A, Foster G, Crownover P, LaBadie R, Glue P.

Br J Clin Pharmacol. 2008 Apr;65(4):531-9. doi: 10.1111/j.1365-2125.2007.03084.x. Epub 2008 Feb 21.

PMID:
18294327
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk